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PTPN12 is an important tumor suppressor that plays
critical roles in various physiological processes.
However, the molecular basis underlying the sub-
strate specificity of PTPN12 remains uncertain.
Here, enzymological and crystallographic studies
have enabled us to identify two distinct structural
features that are crucial determinants of PTPN12
substrate specificity: the pY+1 site binding pocket
and specific basic charged residues along its surface
loops. Key structurally plastic regions and specific
residues in PTPN12 enabled recognition of different
HER2 phosphorylation sites and regulated specific
PTPN12 functions. In addition, the structure of
PTPN12 revealed a CDK2 phosphorylation site in a
specific PTPN12 loop. Taken together, our results
not only provide the working mechanisms of
PTPN12 for desphosphorylation of its substrates
but will also help in designing specific inhibitors of
PTPN12.INTRODUCTION
PTPN12, a recently characterized tumor suppressor, has been
demonstrated as a pivotal regulator of EGFR/HER2 signaling
and is required for embryonic development (Cao et al., 2012,
2015; Zheng et al., 2013; Sun et al., 2011; Souza et al., 2012;
Luo et al., 2014; Albeck and Brugge, 2011). PTPN12 knockout
mice are embryonic lethal. In addition to its important role in
growth and development, PTPN12 regulates various physiolog-
ical processes, including cell migration, immune response, and
neuronal activity, by dephosphorylating multiple substrates
(Lee et al., 2015; Rhee et al., 2014; Espejo et al., 2014; RheeCe
This is an open access article under the CC BY-Nand Veillette, 2012; Zheng et al., 2009; Angers-Loustau et al.,
1999; Garton and Tonks, 1999). At least 18 PTPN12 sub-
strates have been identified, including HER2, FAK, PYK2,
PSTPIP, WASP, p130Cas, paxillin, Shc, catenin, c-Abl, ArgBP2,
p190RhoGAP, RhoGDI, cell adhesion kinase beta (CAKb), and
Rho GTPase (Rhee et al., 2013; Zheng et al., 2011; Davidson
et al., 2010; Espejo et al., 2010; Chellaiah et al., 2007; Veillette
et al., 2009; Davidson and Veillette, 2001; Badour et al., 2004;
Lyons et al., 2001; Cong et al., 2000; Spencer et al., 1997).
Although cellular studies have demonstrated that the phos-
phorylation states of these substrates are tightly controlled by
PTPN12, the molecular basis of how PTPN12 specifically recog-
nizes and dephosphorylates these proteins remains elusive. In
the present study, we combined enzymological, structural, and
cellular approaches to dissect the substrate specificity and po-
tential regulatory mechanisms of PTPN12. Cellular studies and
kinetic analysis revealed that PTPN12 dephosphorylates spe-
cific phosphorylation sites on HER2 and shows a preference to-
ward specific primary phospho-peptide sequences and for small
artificial substrates. To provide deeper insight into the substrate
specificity of PTPN12, we solved the crystal structure of a
somatic cancer mutant of PTPN12, PTPN12-K61R. Structural
analysis together with mutagenesis studies revealed crucial
structural features that determine the substrate specificity of
PTPN12, including its pY+1 site, key basic residues in its surface
loops, and structurally plastic elements. The specific structural
features of PTPN12 and the interaction with different HER2
phosphorylation sites were also shown to play important roles
in the modulation of specific PTPN12 functions.
RESULTS
Substrate Selectivity and Biochemical Properties of
PTPN12
Two PEST domain-containing phosphatases, PTPN12 and
BDP1 (also called PTPN18), have been characterized as potentll Reports 15, 1345–1358, May 10, 2016 ª 2016 The Authors 1345
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Substrate Specificity and Kinetic Analysis of PTPN12
(A) Schematic representation of HER2 activation and its intracellular tyrosine phosphorylation sites.
(B) PTPN12 knockdown potently enhances EGF-induced HER2 tyrosine phosphorylation in the MDA-231 cell line. Representative western blots from three
independent experiments are shown. The phosphorylation statuses of tyrosines at sites 1112, 1139, 1196, 1221/1222, and 1248 were detected using specific
antibodies.
(legend continued on next page)
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negative regulators of HER2 signaling (Wang et al., 2014; Sun
et al., 2011). HER2 contains multiple tyrosine phosphorylation
sites, which mediate its diverse functions (Figure 1A). We have
previously revealed that BDP1 specifically regulates HER2 func-
tion through selective dephosphorylation of HER2’s C-terminal
pY1112, pY1196, and pY1248 sites. However, the specific phos-
phorylation sites of HER2 that are targeted by PTPN12 remain
unknown. Therefore, we knocked down PTPN12 expression
using small interfering RNA (siRNA) and monitored the phos-
phorylation levels of HER2-specific tyrosines after epidermal
growth factor (EGF) stimulation in MDA-231 breast cancer cells.
Reducing the expression of PTPN12 via knockdown signifi-
cantly increased the phosphorylation of HER2’s pY1112, pY1196,
pY1221/1222, and pY1248 sites, but not its pY1139 site (Figures 1B
and 1C). These data indicate that PTPN12 has broader substrate
specificity toward HER2 phosphorylation sites than does BDP1.
Both ours and many other studies have shown that the cata-
lytic domains of several PTPs contribute to substrate specificity
by providing recognition of the local microenvironments sur-
rounding tyrosine phosphorylation sites, such as primary pep-
tide sequence signatures (Salmeen et al., 2000; Wang et al.,
2014; Chen et al., 2015). We therefore examined the phospha-
tase activity of PTPN12 on a collection of phospho-peptides
derived from HER2 and other potential substrates of PTPN12
(Figure 1D; Figure S1A; Table S1). Consistent with the results
from cellular studies, PTPN12 displayed reasonable kcat/Km
values toward phospho-peptides derived from HER2 corre-
sponding to the pY1221, pY1222, pY1248, pY1196, and pY1112 sites
and toward a phospho-peptide derived from the CDH2 pY785
site. These values ranged from 13 106 to 43 106 M1s1, which
are close to the kcat/Km values of other PTPs toward their corre-
sponding physiological substrates (Yu et al., 2011; Wang et al.,
2014; Li et al., 2014). In contrast, PTPN12 was found to have
low activity toward seven other phospho-peptides. Interestingly,
PTPN12 typically favored acidic residues at the pY-4 and pY-1
positions among its top four phospho-peptide substrates. These
results imply that specific structural features of PTPN12’s cata-
lytic domain may contribute to its substrate specificity. Notably,
the pY1112 site of HER2 shared no primary sequence signatures
at the pY-4 and pY-1 positions. Therefore, alternative mecha-
nisms exist to define substrate specificity of PTPN12.
We next set out to delineate key residues of HER2-phospho-
peptides recognized by PTPN12 by examination of the activity
of wild-type PTPN12 (PTPN12-WT) toward three alanine-
scanned HER2-phospho-peptide libraries derived from HER2
pY1248, pY1196, and pY1112 sites, by substituting each amino
acid surrounding pY to alanine (Figures 1E–1G; Table S2). Com-
mon significant effects were imposed on PTPN12-WT by alanine
scanning of the HER2 pY1248 and pY1196 sites at the following
three positions: pY-4 (E1244/E1192), pY-1 (E1247/E1195), and
pY+1 (L1249/L1197) (Figures 1E–1G; Table S2). Interestingly,
the key residue positions of the primary sequence of the(C) The tyrosine phosphorylation level in (B) was quantified by densitometry and i
PTPN12 siRNA-treated cells were compared with control siRNA-treated cells.
(D) Phosphatase activities of PTPN12 toward a panel of phospho-peptides.
(E–G) Phosphatase activities of PTPN12-WT toward the alanine-scanning phosph
or the HER2 pY1112 site (G).HER2- pY1112 site that are recognized by PTPN12 are entirely
different from its counterparts pY1248 and pY1196—pY-3
(L1109), pY+2 (E1114), and pY+3 (D1115). Therefore, at least
two different phospho-sequence interaction modes were
preferred by PTPN12.
We then probed the properties of the active site of PTPN12 by
examining the phosphatase activity of PTPN12 toward small arti-
ficial substrates, and we compared these findings with those
generated by two other phosphatases of the PTP-PEST subfam-
ily. As shown in Figure S1B and Table S3, all three PEST family
phosphatases preferred the double-ring substrate DiFMUP
over the single-ring substrate pNPP and the multiple-ring sub-
strate OMFP. The Km value of PTPN12 toward DiFMUP or
OMFP was 60- or 100-fold smaller than its Km value toward
pNPP, suggesting its active site can accommodate substrates
greater than a single phospho-tyrosine (Figure S1B; Table S3).
Taken together, these biochemical results provided a glimpse
for PTPN12 substrate recognition and further detailed structural
and biochemical analysis are required to understand the sub-
strate specificity of PTPN12.
Crystal Structure of the Catalytic Domain of PTPN12
To visualize the molecular architecture of PTPN12 and provide a
structural basis for its substrate specificity, we attempted to
determine its crystal structure. The crystallization of PTPN12-
WT was unsuccessful; however, diffraction-quality crystals cor-
responding to the catalytic domain of a somatic cancer mutant
(K61R) of PTPN12 have been obtained (Takekawa et al., 1994)
with R3 space-group symmetry. Therefore, the structure of the
catalytic domain of PTPN12 was solved by molecular replace-
ment using the coordinates of Lyp (also called PTPN22) (PDB:
2QCT) as a search model and could be refined to 2.0 A˚ (Table
S4) (Sun et al., 2007). The final refined structure of PTPN12
resembled the classic PTP fold, possessing central b sheets
flanked by a helices on each side (Figure 2A). This a+b structure
of PTPN12 enables it to present key loops surrounding the P loop
that constitutes its active site. Whereas PTPN12’s WPD-loop
and Q-loop are located along one side of its P loop and harbor
important catalytic residues, including D199, Q278, and Q282,
its pY-loop, b10-loop-b1, and b3-loop-b4 all reside on the oppo-
site side andmay contribute to substrate recognition (Figure 2A).
Importantly, four regions of PTPN12 displayed substantial
conformational differences compared to two other PEST family
PTPs, including the WPD-loop, b1-loop-b2, b3-loop-b4, and
a10-helix (Figures 2B and 2C). Without an anion in the active
site, theWPD-loop of PTPN12 exists in a half-open conformation
that resembles something between the closed conformation of
apo-BDP1 and the open conformation of apo-Lyp (Figure S1C).
In addition to theWPD-loop, structural alignment of the b10-loop-
b1 loop and the a10-helix produced root-mean-square deviation
(RMSD) values larger than 5 A˚ for PTPN12 compared to the other
two PTP-PEST family members, BDP1 and Lyp (Figures 2B, 2C,s displayed as a ratio against an unstimulated control. **p < 0.01, ***p < 0.005.
o-peptide library derived from the HER2 pY1248 site (E), the HER2 pY1196 site (F),
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Figure 2. Crystal Structure of the PTPN12 Catalytic Domain
(A) Ribbon diagram of the PTPN12 catalytic domain with specific loops surrounding the active site highlighted in different colors.
(B and C) Plot of distance RMSDs of individual residues between crystal structures of different PTPs in the PEST subfamily. (B) PTPN12 versus BDP1
(PTPN18). (C) PTPN12 versus Lyp (PTPN22). Large structural deviations were observed in specific regions, including the a10, b10-loop-b1, b3-loop-b4, and the
WPD-loop.
(legend continued on next page)
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and 2E). Different residues in the surface loops of different PTP-
PEST family members create distinct surface electrostatic po-
tentials, a property that may be linked to substrate recognition
or interactions with regulatory proteins. Similar to Lyp, PTPN12
possesses a continuous, basic, charged groove. In particular,
PTPN12 has a specific acidic patch in the vicinity of its active
site. These structural differences between PTPN12 and the other
PTP-PEST family members may play important roles in the
substrate recognition and functional selectivity of PTPN12
(Figure 2D).
Higher-order architecture of PTPN12 was identified in the
crystallographic asymmetric unit, which contained four mole-
cules of the PTPN12 catalytic domain that were related by
non-crystallographic symmetry (NCS) operators (Figures S1D
and S2A–S2C). Whereas the dimer interface of molecule A/B is
mediated by symmetric interactions in the long b3-loop-b4 (Fig-
ure S2B), the A/C dimer interface is composed of interactions
between residues in b10-loop-b1, b4, and b6-loop-b7 frommole-
cule A and residues in the a2-helix and a3-loop-b8 from mole-
cule C (Figure S2C). Although gel filtration results excluded the
formation of the PTPN12 dimer in vitro (Figure S2D), these re-
gions involved in the dimer interfaces may serve as potential
docking sites for specific interactions with cellular signaling part-
ners. We next compared the RMSD between different molecules
in each asymmetric subunit (Figure S2E). Two discrete regions,
the b10-loop-b1 and the WPD-loop, which are key elements
that possess structural differences between PTPN12 and the
two other PTP-PEST family members, also showed great struc-
tural plasticity, with RMSD values larger than 2 A˚ between
different molecules within one asymmetric unit. More impor-
tantly, these two loops surround the active site, thus enabling
alternative local surfaces to be formed for differential substrate
recognition, suggesting the potential functional importance of
these regions (Figure 2A).
Key Surface Loop Residues in the Catalytic Domain of
PTPN12 Confer Substrate Specificity toward Phospho-
peptides
Enzymologic studies revealed that PTPN12 shows primary
sequence preferences toward phospho-peptide substrates,
and crystallographic analysis indicated that special structural
features may underlie PTPN12 substrate recognition. We
therefore selected residues localized on the surface loops sur-
rounding the active site of PTPN12 and evaluated the effects
of mutations at these positions on PTPN12 phosphatase activity
(Figures 2E and 3A–3E).
Among 26 tested mutations, 8 mutations decreased the
kcat/Km of PTPN12 toward the small artificial substrate pNPP
(Figure 3B). All of the residues that affected the intrinsic activity
of PTPN12 are localized in the important loops of the catalytic
site, including the phospho-tyrosine recognition loop (pY-loop),
the WPD-loop, and the Q-loop. The R63A and Y64A mutations(D) The surface electrostatic potentials of three PEST family members, which w
represent positively charged (+4) and negatively charged (4) surface elements,
(E) Structure-based sequence alignment of PTPN12 from different species toge
MEG2, and PTP1B. Bold residues indicate selected mutations used for enzymati
activity. Residues colored orange, blue, purple, or red indicate mutations that imsignificantly increased the Km by more than 3-fold, indicating
that these residues, which lie in the pY-loop, are important for
substrate binding (Table S5). The D199A, H200A, and H200R
mutations significantly impaired the kcat of PTPN12 toward
pNPP but had insignificant effects on Km, suggesting that these
residues are important for PTPN12 catalysis (Table S5). D199
acts as an acidic donor of an important hydrogen to the leaving
group during catalysis. H200 is close to D199, and an equivalent
position in PTP1B, F182, has been shown to regulate the correct
conformation of the corresponding acid during catalysis (Peder-
sen et al., 2004). Mutations of three residues in the Q-loop—
R270A, S275A, and K280E—increased the Km of PTPN12
toward pNPP, suggesting these residues either participate in
pNPP binding or are important for the correct conformations of
catalytically important glutamines (Table S5).
To investigate the key residues important to the local environ-
ment that provides substrate specificity, we next examined the
effects of the above 26 mutations toward phospho-peptides
derived from HER2 pY1112, HER2 pY1196, and HER2 pY1248 sites
(Figures 3C–3E; Table S6). Similar to their effects on pNPP hy-
drolyzation, the Y64A, D199A, and S275Amutations significantly
decreased the activity of PTPN12 toward all three HER2 phos-
pho-peptides (Figures 3C–3E; Table S6). Y64 is a conserved res-
idue among PTP superfamily members and has been shown to
form hydrophobic stacking interactions with the phenyl rings of
the phospho-tyrosines in several PTP/phospho-peptide com-
plexes (Sun et al., 2003; Yu et al., 2011; Salmeen et al., 2000;
Wang et al., 2014). D199 stabilizes the enzyme/substrate inter-
mediate that is required for substrate hydrolysis. Although these
conserved residues are important for phospho-tyrosine binding
and hydrolysis, they do not significantly contribute to specific
phospho-sequence recognition.
Importantly, 12 mutants were significantly more effective in
decreasing the activity of PTPN12 toward at least one of the
HER2-phospho-peptides than toward the small substrate
pNPP, indicating these residues recognize a location on the
HER2 phospho-peptide other than the phenyl-phosphate region
of the substrate (Figures 3B–3E). Surrounding the active site of
PTPN12, the pY-loop and Q-loop harbor important residues for
substrate recognition. Previous studies have shown that the res-
idues equivalent to the D66 position of PTPN12 in BDP1, LYP,
and PTP1B help determine phospho-peptide orientation by
forming hydrogen bonds with the amides of pY and pY+1 resi-
dues (Sun et al., 2003; Yu et al., 2011; Salmeen et al., 2000;
Wang et al., 2014). Accordingly, the D66A mutation significantly
impaired the activity of PTPN12 toward all three HER2-phospho-
peptides, suggesting that D66 in PTPN12 has a similar role in
substrate recognition (Figures 3A–3E). The residues equivalent
to position I67 in the pY-loop and Q278 in the Q-loop have
been shown to form two sides of the binding pocket made of
pY+1 residues in BDP1/HER2-pY1196 and PTP1B/IRK-pY1162/
pY1163 complex structures (Salmeen et al., 2000; Wang et al.,ere calculated using an APBS-plugin in PyMOL. The blue and red surfaces
respectively. From left to right: PTPN12, BDP1 (PTPN18), and Lyp (PTPN22).
ther with other PTP members, including Lyp (PTPN22), BDP1 (PTPN18), PTP-
c assays. Residues shaded black indicate mutations that impaired the intrinsic
paired the intrinsic activity or substrate specificity, respectively.
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2014). Mutation of these two residues to Ala significantly
decreased the ability of PTPN12 to dephosphorylate the HER2
pY1248 and pY1196 phospho-peptides, indicating the importance
of these residues in phospho-peptide selectivity (Figures 3D
and 3E).
Two discrete regions, the b3-loop-b4 and WPD-loop of
PTPN12, have great structural diversity as shown by structural
alignment (Figure 2B). Elimination or reversion of the basic
charges of two residues along the b3-loop-b4 (R140 and K141)
or of H200 in the WPD-loop by substitution with Glu or Ala signif-
icantly impaired the dephosphorylation of all three HER2-phos-
pho-peptides by PTPN12 (Figures 3A–3E). These residues may
participate in charge-charge interactions between PTPN12 and
these phospho-peptide substrates, especially considering the
highly acidic nature of the phospho-peptides. Notably, these
residues substantially vary among different PTP-PEST family
members and thus may be important for substrate specificity
in individual PTPs (Figure 2E). Moreover, basic residues R36
and K46 are located in the a20-a1 region; the K142 located
in the b3-loop-b4 region and the H274 located in the Q-loop
exhibit selectivity by discriminating among phospho-peptide
substrates derived from different HER2 sites, demonstrating
that these distinct basic charged surface residues provided spe-
cific structural features for recognition of the different phospho-
sites by a single phosphatase (Figures 3C–3H) (Wang et al.,
2014).
Mechanism Underlying the Specific Acidic Residue
Preference and Substrate Selectivity of the pY+1
Position of PTPN12 toward HER2-pY1248 and pY1196
Sites
To further delineate the specific interactions that mediate the
complex formation of PTPN12 with its substrate, the HER2-
pY1196 and pY1248 phospho-peptides, we examined the activities
of specific PTPN12 mutants toward the alanine-scanned HER2-
pY1248 or HER2-pY1196 phospho-peptide libraries and com-
pared the results with the PTPN12-WT to clarify how PTPN12
selectively recognizes these residues (Figures 3F and 3G;
Figures S3A–S3R; Table S7). Seven of the PTPN12 mutations
could discriminate between the HER2-pY1248 phospho-peptide
harboring the E1244A mutation or the HER2-pY1196 phospho-
peptide harboring the E1192A mutations and their WT counter-
parts by a factor of 2-fold, which was similar to PTPN12-WT;
however, the K141E mutation showed no significant preference
(Figures S3A–S3R; Table S7). Therefore, K141 specifically inter-Figure 3. Kinetic Analysis Revealed Common and Specific Features in
Phosphorylation Sites
(A) Structural representation of the locations of designed mutations on the sur
phospho-peptide/PTPN12 interactions. The P loop is labeled in red.
(B) The catalytic activity of PTPN12-WT and different mutants toward pNPP.
(C–E) The catalytic activity of PTPN12-WT and differentmutants toward the HER2
Mutants responsible for all three phospho-peptide binding are yellow; residue spe
recognizing HER2-pY1248 phospho-peptide is saddle brown; residues that only in
are purple; and residues that only interact with HER2-pY1112 phospho-peptide a
(F–H) Schematic representation of interactions between PTPN12 and HER2-pY12
phospho-peptide (H) that are deduced from analysis of the activities of the PTP
phosphorylation sites (Figures S4J–S4L).
In (B)–(E): *p < 0.05, **p < 0.01, ***p < 0.005. The enzymatic activity of each specacts with E1244 on the HER2-pY1248 or E1192 of the HER2-
pY1196 phospho-peptides (Figures 3F and 3G). The R63A and
R140E mutations specifically impaired PTPN12’s favoring of
E1247 of the HER2-pY1248 or E1195 of the HER2-pY1196, sug-
gesting these two positively charged residues specifically
interact with the acidic residue at the pY-1 position of the
HER2-pY1248 phospho-peptide (Figures S3A–S3R; Table S7).
The mutation of two other positively charged residues, R36A in
the a20-a1 region and K280E in the Q-loop, specifically elimi-
nated the preference for the D1252 residue of the HER2-pY1248
phospho-peptide, indicating that a specific interaction forms be-
tween R36, K280, and the pY+4 acidic residue of the phospho-
peptide (Figure 3F; (Figures S3A–S3I; Table S7). The orientation
of the HER2-pY1248 or HER2-pY1196 phospho-peptides in com-
plex with PTPN12 should be similar to phospho-peptide/BDP1
or phospho-peptide/Lyp complexes, as all of these phospha-
tases recognize specific C-terminal residues of these phos-
pho-peptides in similar regions, primarily specific residues in
both the ‘‘Lyp-specific insert’’ and the Q-loop.
Specifically, mutation of I67 in the pY-loop and Q278 in the
Q-loop abolished the preference of L1249 in the HER2-pY1248
or L1197 in the HER2-pY1196 phospho-peptides (Figures S3A–
S3R; Table S7). These two residues, together with D66, C235,
H274, and S275, constitute the pY+1 pocket, a demonstrated
key structural feature of substrate specificity in both BDP1 and
PTP1B (Figures 4A–4C). In addition to the hydrophobic nature
of I67, C235, and the aliphatic carbon chain Q278, which favors
a hydrophobic residue at this position, the basic nature of
H274 helps accommodate an acidic residue at this position.
Therefore, PTPN12 shows broader residue preferences at the
pY+1 position than does BDP1, which can only accommodate
acidic residues, such as D786 in the CDH2 pY785 phospho-
peptide. Consistently, BDP1 did not dephosphorylate HER2-
pY1221pY1222, whereas PTPN12 displayed good activity toward
this site both in vivo and in vitro (Figures 1B–1D) (Wang et al.,
2014).
Taken together, the above studies revealed that PTPN12 rec-
ognizes the HER2 pY1248 or pY1196 phosphorylation sites by
forming specific interaction pairs, including the following:
K141 of PTPN12 versus E1244 or E1192 of HER2; R63 and
K140 of PTPN12 versus E1247 or E1195 of HER2; and R36
and K280 of PTPN12 versus D1252 of HER2 (Figures 3F and
3G; Figures S3A–S3R and S4). In addition, the pY+1 binding
site in PTPN12 favors both hydrophobic and acidic residues
(Figure 4A).Mediating Substrate Specificity of PTPN12 toward Different HER2
face loops surrounding the active site of PTPN12, which may be involved in
pY1112 peptide (C), theHER2 pY1196 peptide (D), or the HER2 pY1248 peptide (E).
cifically recognizing HER2-pY1112 phospho-peptide is red; residue specifically
teract with HER2-pY1196 phospho-peptide and HER2-pY1248 phospho-peptide
nd HER2-pY1248 phospho-peptide are blue.
48 phospho-peptide (F), HER2-pY 1196 phospho-peptide (G), and HER2-pY1112
N12 mutants toward alanine-scanning libraries derived from different HER2-
ific mutant is compared with that of PTPN12-WT.
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Figure 4. Impact of Substrate Specificity of PTPN12 on its Cellular Functions
(A–C) Structural representation of the substrate specificity of the pY+1 site binding pocket of PTPN12 (A) compared with the pY+1 pockets of BDP1 (PTPN18) (B)
and PTP1B (C). Residues comprising the pY+1 pocket are shown in stick/ball mode and are colored according to element type.
(D and E) Effects of PTPN12 mutants R36A, K46A (D) and R63A, K142A, H274A (E) on EGF-induced HER2 phosphorylation at positions 1112, 1196, and 1248.
PTPN12-WT was used as a control. MDA231 cells were starved and treated with 25 ng/ml EGF for 5 min, and the phosphorylation status of the specific tyrosine
site at HER2 was detected by specific antibodies. Representative western blots from three independent experiments are shown.
(legend continued on next page)
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An Alternative Interaction Mode between the PTPN12
and HER2- pY1112 Site
Distinct from the preference for acidic residues located at the
pY-4 and pY-1 positions and the hydrophobic residue at the
pY+1 position in the HER2-pY1248 and HER2-pY1196 sites,
PTPN12 selectively recognized a hydrophobic residue at pY-3
and two acidic residues at the pY+2 and pY+3 positions of the
HER2-pY1112 site, suggesting a different interaction mode exists
for phospho-site recognition (Figure 1G). Using alanine scanning
with specific PTPN12 mutants, it was determined that the I67
located in the pY-loop of PTPN12 forms a hydrophobic interac-
tion with L1109 of the HER2-pY1112. At the C-terminal region of
the HER2-pY1112 phospho-peptide, whereas the R63 of the
pY-loop interacted with D1115, the E1114 residue forms specific
interactions with R270 and H274 of the Q-loop of PTPN12 site
(Figure 3H; Figure S4; Table S7). Specifically, H274 is specific
in PTPN12 compared to other PEST-PTP family members but
is conserved among PTPN12 members from different species,
suggesting a functional importance of this residue in governing
substrate specificity of PTPN12 (Figure 2E).
Impact of the Substrate Specificity of PTPN12 on its
Cellular Functions
The combination of the structural analysis and enzymological
determination identified a distinct structural basis for PTPN12
recognition of different HER2 phosphorylation sites, which
include the following: (1) the specific interaction of the H274 of
PTPN12 with the HER2-pY1112 site, (2) the specific interaction
between the K142 of PTPN12 and the HER2-pY1248 site, (3) spe-
cific interactions between the R36 of PTPN12 with the HER2-
pY1112 and HER2-pY1248 sites, and (4) specific interactions
between the K46 of PTPN12 with the HER2-pY1196 and HER2-
pY1248 sites (Figures 3F–3H). Therefore, the R36A is a biased
PTPN12 mutant that only regulated the HER2-pY1196 phosphor-
ylation state, whereas the K46A is a HER2-pY1112 biasedmutant.
Similarly, K142 is a HER2-pY1112 and HER2-pY1196 biased
mutant, and the H274 is a HER2-pY1196 and HER2-pY1248 biased
mutant. These biased mutants are useful tools to evaluate the
signaling mediated by distinct HER2 C-terminal phosphorylation
sites. To further evaluate these specific interactions between
PTPN12 and specific HER2 phosphorylation sites in a more
physiological context, we overexpressed WT PTPN12 and the
mutants R36A, K46A, R63A, K142A, and H274A in MDA-231
breast cancer cells and assessed their effects on EGF-induced
HER2 phosphorylation, ubiquitination, and cell proliferation and
migration (Figures 4D–4I; Figures S5A–S5H).
In MDA-231 cells, PTPN12-WT suppressed all three HER2
phosphorylation sites, but PTPN12-R63A showed no effect on
any of the phosphorylation sites (Figure 4E). For biased mutants,
the PTPN12-R36A mutant only decreased a single HER2 phos-
phorylation site at pY1196, and the K46A mutant only dephos-(F and G) Effects of PTPN12 mutants R36A, K46A (DF) and R63A, K142A, H274A (
domain WT or different mutants were co-transfected with HA-ubiquitin in MDA23
proteins were immunoprecipitated by anti-HA resin and subjected to western blot
antibody. Representative western blots from three independent experiments are
(H and I) Effects of PTPN12-WT or different mutants on EGF-inducedMDA231 cel
PTPN12-WT or mutants were compared with cells transfected with control plasmphorylates HER2-pY1112 (Figure 4D). Overexpression of the
PTPN12-K142A decreased the HER2 pY1196 and pY1112 phos-
phorylation states but left the HER2 pY1248 site untouched,
whereas overexpression of PTPN12-H274A decreased the
phosphorylation of the HER2 pY1196 and pY1248 sites but not
the HER2 pY1112 site (Figure 4E; Figures S5A–S5F). Interestingly,
in functional assays and compared to theWT, the PTPN12-K46A
mutant has similar effects on the HER2-ubiquitination state but
lost its ability to suppress cell proliferation and cell migration
(Figures 4F, 4H, and 4I; Figures S5G and S5H). In contrast,
compared to the WT, the PTPN12-H274 mutant inhibited both
the cell growth and cell motility to a comparable extent but
showed no significant effect on HER2 ubiquitination. As the
K46A only dephosphorylated the HER2-pY1112 site and the
H274A only left the HER2-pY1112 phosphorylation, these obser-
vations suggested that the HER2-pY1112 site only regulates
HER2 ubiquitination. Moreover, the overexpression of R36A,
which only suppressed HER2-pY1196 phosphorylation, only
impaired HER2 function in cell migration, suggesting HER2-
pY1196 is involved in cell motility but not cell growth or HER2
ubiquitination (Figures 4E and 4G–4I). Compared with PTPN12-
WT, overexpression of PTPN12-K142A led tomore cell migration
and cell proliferation, which corresponds to its maintenance of
the HER2 pY1248 phosphorylation state, suggesting that HER2
pY1248 phosphorylation is involved in both cell migration and pro-
liferation (Figures 4E and 4G–4I). Taken together, these results
not only demonstrated that the specific interactions between
the PTPN12 and specific HER2 phosphorylation sites revealed
by biochemical and structural studies were preserved in a
cellular context but also provided important evidence of how
specific structural features of PTPN12 contributed to the modu-
lation of HER2-phosphorylation states at selective sites that
regulated specific HER2 functions.
A PTPN12-Specific Loop Harbors a CDK
Phosphorylation Site
The crystal structure of the PTPN12 catalytic domain revealed a
PTPN12-specific loop (residue numbers 19–26) inserted be-
tween the a10- and a20-helices that is not found in other PTP
family members (Figure 5A). Interestingly, sequence analysis
revealed that the residue sequence MKS19P20DH22NG in
PTPN12 is similar to the consensus CDK2/CDK5 phosphoryla-
tion motif (S/T)-P-X-(K/R/H) (Figure 5B) (Brown et al., 1999; Kita-
gawa et al., 1996; Huang et al., 2006). To determine whether
CDK2 can directly phosphorylate PTPN12, we incubated the
PTPN12 catalytic domain with recombinant CDK2 and cyclin A
in the presence of ATP. PTPN12 phosphorylation wasmonitored
using a specific CDK2-substrate antibody (recognizing the motif
pS-P-X-(K/R/H)) (Brown et al., 1999; Kitagawa et al., 1996;
Huang et al., 2006). As shown in Figure 5C, the PTPN12 cata-
lytic domain is phosphorylated by CDK2 in a time-dependentG) on EGF-induced HER2 ubiquitination. Plasmids encoding PTPN12-catalytic
1 cells. After 4 hr EGF stimulation, MDA231 cells were lysed and ubiquitinated
. Ubiquitinated HER2 was detected by immunoblotting of HER2 with a specific
shown.
l proliferation (H) or cell migration (I). *p < 0.05, ***p < 0.01. Cells overexpressing
ids. PTPN12 mutant was compared with PTPN12-WT.
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Figure 5. CDK2 Interacts with and Phosphorylates S19 in a PTPN12-Specific Loop
(A) Ribbon diagram showing a potential CDK2 phosphorylation site in the PTPN12-specific loop. The predicted CDK phosphorylation site S19 and a known PKC
phosphorylation site S39 are displayed as orange spheres. The conserved residues P20 and H22 are shown as sticks.
(B) Sequence alignment of the PTPN12-specific loop and the surrounding regions of PTPN12 from different species and other PTP members. The CDK2
consensus phosphorylation motif is highlighted.
(legend continued on next page)
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manner. In particular, the S19Emutation, but not the known PKC
phosphorylation-site S39E mutation, abolished the phosphory-
lation of PTPN12 by CDK2, indicating that CDK2 mainly
phosphorylates the PTPN12 catalytic domain at position S19
(Figure 5D). To further determine whether CDK2 could phos-
phorylate PTPN12 in vivo, we co-expressed HA-CDK2 and
Flag-PTPN12 in HEK293 cells. A co-immunoprecipitation ex-
periment demonstrated the formation of a PTPN12/CDK2
complex (Figure 5E). Moreover, the phosphorylation level of
PTPN12 was proportional to the increased expression of
CDK2, whereas the S19A mutant increased to a lesser extent
in HEK293 cells, suggesting that position S19 is a phosphoryla-
tion site that is regulated by CDK2 in vivo (Figures 5F and 5G;
Figure S5I).
DISCUSSION
PTPN12 is a recently characterized tumor suppressor that an-
tagonizes EGFR/HER2 signaling (Zheng et al., 2013; Sun et al.,
2011). In addition to the mutations and gene deletion of
PTPN12 found in breast cancer, decreased expression of
PTPN12 is also correlated with poor prognoses in individuals
with non-small-cell lung cancer, esophageal squamous cell car-
cinoma, or hepatocellular carcinomas (Cao et al., 2012, 2015;
Luo et al., 2014). The cellular functions of PTPN12 have been
extensively investigated. For example, PTPN12 not only directly
dephosphorylates EGFR and HER2 but also functions as a
key switch downstream of receptor signaling that regulates cell
invasion and morphogenesis (Zheng et al., 2013; Sun et al.,
2011). At least 18 physiological substrates of PTPN12 have
been identified; they mediate important PTPN12 functions in
cell motility, immune response, and neuronal signaling (Table
S8). Among the known PTPN12 substrates, the explicit phos-
phorylation sites of at least 12 have been identified (Table S8).
However, both the mechanism and the structural details under-
lying how PTPN12 recognizes these specific sites remain poorly
understood.
Recent studies by our and other research groups have demon-
strated that specific structural features of the catalytic domains
of protein tyrosine phosphatases play important roles in deter-
mining substrate specificity through discrimination of the local
microenvironment of the pY site of the substrate (Salmeen
et al., 2000; Wang et al., 2014; Yu et al., 2011; Parker, 2015). In
the present study, using systematic mutagenesis and the(C) Time-dependent phosphorylation of PTPN12 by CDK2 in vitro. A total of 50 m
cyclin A in the presence of 1mMATP at 37C. The reactions were terminated at dif
by an anti-phospho-CDK2-substrate antibody.
(D) Identification of S19 in the PTPN12 catalytic domain as the phosphorylation s
incubated with or without 1 mM ATP or 10 mM CDK2 + 1 mM cyclin A at 37C fo
phospho-CDK2-substrate antibody.
(E) Formation of the CDK2/PTPN12 complex in cells. HEK293 cells were co-trans
anti-HA affinity agarose, and the formation of the CDK2/PTPN12 complex was e
(F) Dose-dependent phosphorylation of PTPN12 at site S19 following the overex
amounts of plasmids encoding CDK2 in HEK293 cells. PTPN12 was immunoprec
CDK2 was examined.
(G) The S19A mutation significantly reduced the phosphorylation of PTPN12 by C
CDK2. Flag-tagged PTPN12 was immunoprecipitated, and the phosphorylatio
antibody.HER2-pY1248 phospho-peptide as a model substrate, we have
identified the following two distinct structural features that deter-
mine the substrate specificity of PTPN12: the pY+1 binding site
pocket and the combination of basic charged residues in
PTPN12’s surface loops (Figures 3A, 3F–3H, and 4A; Figures
S3 and S4A–S4L). Kinetic studies and crystal structures of the
PTP1B/IR-phospho-peptide and BDP1/HER2-phospho-peptide
complexes have revealed the specific properties of the pY+1
binding site pocket that play important roles in substrate recog-
nition in PTPs (Salmeen et al., 2000; Wang et al., 2014). In addi-
tion, seven PTPs (SHP1, SHP2, TCPTP, MEG2, PTPBAS, DEP1,
and GLEPP1) are proposed to have specific pY+1 sites that may
determine the substrate specificity that are located on the C-ter-
minal side of the central phospho-tyrosine (Barr et al., 2009; Villa
et al., 2005). Whereas the hydrophobic residues V65, C233,
P272, and A273 that constitute the pY+1 site binding pocket
restrict BDP1 to selectively interact with hydrophobic residues,
the substitution of P272 in BDP1 with H274 in PTPN12 provides
PTPN12 with a broader substrate specificity, allowing it to
interact with both hydrophobic and acidic residues. While
BDP1 can selectively dephosphorylate three of the nine HER2/
EGFR phosphorylation sites, PTPN12 possesses broader sub-
strate specificity, being able to dephosphorylate four of five
HER2 phosphorylation sites (Figures 1A–1C). In vitro, although
HER2-pY1248/HER2-pY1196 and CDH2-pY785 have different res-
idues at their pY+1 sites (hydrophobic Leu or acidic Asp, respec-
tively), all of the phospho-peptides derived from these sites are
good substrates for PTPN12 (Figure 1D). Of the 12 known
PTPN12 substrates, 3 of them have hydrophobic residues (L)
and 3 others have acidic residues (D or E) (Table S8). These re-
sults, together with previous discoveries of the substrate speci-
ficities of PTP1B, PTPN18, and PTPBAS localized at the pY+1
site, suggest that the specific structures found at the pY+1 site
binding pocket determine the substrate specificities of at least
a subset of PTP superfamily members.
Another noteworthy structural feature distinctive to the sub-
strate specificity of PTPN12 is the presence of groups of basic
charged residues localized in its surface loops, which are
responsible for the recognition of acidic residues at specific po-
sitions in phospho-peptide sequences, including the pY-4, pY-1,
and pY+4 sites. These basic charged residues include R36 and
K46, which are in proximity to the LYP-specific insert region,
R63 in the pY-loop, R140/K141/K142 in b1-loop-b2, H200 in
the WPD-loop, and R270, H274, and K280 in the Q-loopM of the PTPN12 catalytic domain was incubated with 10 mM CDK2 and 1 mM
ferent time points, and the phosphorylation of PTPN12 by CDK2was examined
ite of CDK2. His-tagged PTPN12-WT, PTPN12-S19E, and PTPN12-S39E were
r 30 min. The phosphorylation of PTPN12 by CDK2 was detected by an anti-
fected with Flag-PTPN12 and HA-CDK2. CDK2 was immunoprecipitated using
xamined using an anti-Flag antibody.
pression of CDK2. Flag-tagged PTPN12-WT was co-transfected with different
ipitated using anti-Flag affinity agarose, and the phosphorylation of PTPN12 by
DK2 in vivo. Either PTPN12-WT or PTPN12-S19A was co-transfected with HA-
n of PTPN12 by CDK2 was examined using a specific anti-CDK2-substrate
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(Figure 3A). 8 out of 10 of these residues are not conserved
among different PTP members, suggesting the importance of
these residues in conferring the substrate specificity of
PTPN12 (Figure 2E). Interestingly, two different modes between
PTPN12 and phospho-HER2 sites have been disclosed, of
which one type of interaction favors acidic residues at the
pY-4 and pY-1 positions and a hydrophobic residue at the
pY+1 position and the other type favors a hydrophobic residue
at the pY-3 position and acidic residues at the pY+2 and pY+3
positions, encompassing the pY sites of HER2 (Figures 1E–1G).
Most importantly, mutation of distinct surface basic charged
residues, including R36, K46, K142, and H274, decreased phos-
phatase activity of PTPN12 toward one or two HER2 phospho-
sites but not other sites, indicating the presence of the specific
structural basis underlying one PTP’s ability to recognize
different substrates (Figures 3C–3H). These results further
supported the hypothesis that a specific inhibitor could be de-
signed to target different substrates of specific PTP members
(Doody and Bottini, 2014). Therefore, our current results provide
important guidance toward designing specific PTPN12 inhibi-
tors that can selectively block the dephosphorylation of single
PTPN12 substrate. The development of such inhibitors would
serve as a valuable tool in investigating the functions of
PTPN12, especially considering its multiple known substrates.
Moreover, our crystal structure unexpectedly identified a
CDK2 phosphorylation site (S19) localized in a PTPN12-specific
loop (Figure 5A). Further cellular studies could help in delin-
eating the significance of the phosphorylation of PTPN12 at
the S19 site.
In conclusion, we have identified distinct structural features of
PTPN12 and specific structurally plastic regions localized in its
catalytic domain that together are involved in the determination
of its substrate specificity, which may not only provide an under-
standing of the mechanism underlying PTPN12’s recognition of
specific substrates but may also facilitate the design of specific
inhibitors.
EXPERIMENTAL PROCEDURES
Phosphatase Assays for Small Artificial Substrates
All phosphatase assays were carried out in 3,3-dimethylglutaric acid (DMG)
buffer ([pH 7.0] 3,3-dimethyl glutarate 50 mM, EDTA 1 mM, DTT 2 mM,
and the ionic strength was adjusted to 0.15 M by NaCl addition) with 96-
well plates at 37C as previously described (Li et al., 2014). All reactions
commenced by mixing enzyme with substrates at different concentrations.
For pNPP, the reaction was terminated by mixing with NaOH and then
measured at 405 nm absorbance. For DiFMUP, the reaction was measured
by excitation at 358 nm and emission was detected at 455 nm. For OMFP,
the reaction was measured by excitation at 485 nm and emission at
525 nm. The data were gathered and analyzed by GraphPad Prism5
(GraphPad Software).
Phosphatase Assays for Phospho-peptides
The peptides were dissolved in water, and the concentration of peptides
was determined by complete dephosphorylation and determination of the
released inorganic phosphate. The phosphatase assay for phospho-peptides
was carried out in DMG buffer with 96-well plates at 37C as previously
described. The reaction was initiated by mixing enzyme with substrates,
was ended by mixing Biomol Green Reagen, and was then measured
at 620 nm absorbance. Finally, the data were analyzed using GraphPad
Prism5.1356 Cell Reports 15, 1345–1358, May 10, 2016Structure Determination and Refinement
The structure of His-PTPN12-K61R was solved by molecular replacement us-
ing Lyp (PDB: 2QCJ) as initial model with the Phaser MR software of the CCP4
software package. The structure was then refined using Phenix and adjusted
iteratively with Wincoot software.
Data Analysis
All kinetic or quantification data are presented as the mean ± SD of more than
three independent experiments. The western blotting results were graphed
and were quantified with ImageJ software. Statistical comparisons were car-
ried out using ANOVA with GraphPad Prism5 software. The sequence align-
ments of PTPN12 with other PTP members were performed by the T-coffee
multiple sequence alignment program. The results of protein structure were
generated with PyMOL.
All other material or methods are included in the Supplemental Information.
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The accession number for the structure of PTPN12-K61R mutant reported in
this paper is PDB: 5J8R.
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